AdipoGen Life Sciences

anti-BimS/EL/L, mAb (3C5)

CHF 420.00
In stock
AG-20T-0142-C100100 µgCHF 420.00
More Information
Product Details
Synonyms BCL2L11; Bcl-2-like Protein 11; Bcl2-interacting Mediator of Cell Death
Product Type Monoclonal Antibody
Properties
Clone 3C5
Isotype Rat IgG2aκ
Immunogen/Antigen Synthetic peptide corresponding to aa 20-40 of mouse BimL.
Application

ELISA
Flow Cytometry
Immunocytochemistry
Immunohistochemistry
Immunoprecipitation: (1-2μg/ml)
Western Blot: (1-5μg/ml)
Optimal conditions must be determined individually for each application.

Crossreactivity Dog
Human
Monkey
Mouse
Rat
Specificity

Recognizes an epitope within aa 20-40 of human, mouse, rat, monkey and dog BimL (~19kDa), BimEL (~23kDa), and BimS (~16kDa). Also recognizes the six novel isoforms of human Bim, generated by alternative splicing and lacking the C-terminal hydrophobic region.

Purity ≥95% (SDS-PAGE)
Purity Detail Protein G-affinity purified (sepharose column).
Endotoxin Content <0.1EU/μg purified protein (LAL test; Lonza).
Concentration 1mg/ml
Formulation Liquid. In PBS containing 0.02% sodium azide and 25% glycerol.
Isotype Negative Control

Rat IgG2a Isotype Control

Shipping and Handling
Shipping BLUE ICE
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice After opening, prepare aliquots and store at -20°C.
Avoid freeze/thaw cycles.
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Description

Bim belongs to the Bcl-2 protein family. Bcl-2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. This protein contains a Bcl-2 homology domain 3 (BH3). It has been shown to interact with other members of the Bcl-2 protein family (BCL2, BCL2L1/BCL-X(L) and MCL1) and to act as an apoptotic activator, inducing apoptosis and anoikis. Several variants have been identified. The isoforms vary in cytotoxicity with isoform BimS being the most potent and isoform BimEL being the least potent.

Product References
  1. Generalized resistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim: A. Liston, et al.; Immunity 21, 817 (2004)
  2. Bim is a suppressor of Myc-induced mouse B cell leukemia: A. Eagle, et al.; PNAS 101, 6164 (2004)
  3. ER stress triggers apoptosis by activating BH3-only protein Bim: H. Puthalakath, et al.; Cell 129, 1337 (2007)
  4. BimS-induced apoptosis requires mitochondrial localization but not interaction with anti-apoptotic Bcl-2 proteins: A. Weber, et al.; J. Cell Biol. 177, 625 (2007)
  5. NF-κB1 and c-Rel cooperate to promote the survival of TLR4-activated B cells by neutralizing Bim via distinct mechanisms: A. Banerjee, et al.; Blood 112, 5063 (2008)
  6. Loss of the BH3-only protein Bmf impairs B cell homeostasis and accelerates γ irradiation-induced thymic lymphoma development: V. Labi, et al.; J. Exp. Med. 205, 641 (2008)
  7. MEK/ERK-Mediated Phosphorylation of Bim is Required to Ensure Survival of T and B Lymphocytes during Mitogenic Stimulation: L.A. O'Reilly, et al.; J. Immunol. 183, 261 (2009)
  8. c-Cbl promotes T cell receptor-induced thymocyte apoptosis by activating the phosphatidylinositol 3-kinase/Akt pathway: C.B. Thien, et al.; J. Biol. Chem. 285, 10969 (2010)
  9. Targeting Activating Transcription Factor 3 by Galectin-9 Induces Apoptosis and Overcomes Various Types of Treatment Resistance in Chronic Myelogenous Leukemia: J. Kuroda, et al.; Mol. Cancer Res. 8, 994 (2010)
  10. OCK8 deficiency impairs CD8 T cell survival and function in humans and mice: K.L. Randall, et al.; J. Exp. Med. 208, 2305 (2011)
  11. Cyclic-AMP-dependent protein kinase A regulates apoptosis by stabilizing the BH3-only protein Bim: D. Moujalled, et al.; EMBO Rep. 12, 77 (2011)
  12. Alternative splicing of Bim and Erk-mediated Bim(EL) phosphorylation are dispensable for hematopoietic homeostasis in vivo: C. Clybouw, et al.; Cell Death Differ. 19, 1060 (2012)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.